Skip to main content
Clinical Trials/NCT02183948
NCT02183948
Completed
Early Phase 1

Effect of Oxytocin on Masked Facial Expressions: an fMRI Study

University of Electronic Science and Technology of China0 sites86 target enrollmentJune 2014

Overview

Phase
Early Phase 1
Intervention
Placebo
Conditions
Facial Expressions
Sponsor
University of Electronic Science and Technology of China
Enrollment
86
Primary Endpoint
Number of participants with neuro activity to facial expressions
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The purpose is to test whether oxytocin has an effect on masked facial expressions

Detailed Description

The neuropeptide oxytocin (OXT) has been shown to modulate several aspects of human social cognition. Although the exact mechanisms behind these effects remain unclear, recent research suggests that OXT modulates the perception of cues that are important for interpersonal processing, particularly emotional facial expressions. Using a backward masking procedure and functional magnetic resonance imaging, we investigated the modulatory effects of intranasal OXT on the processing of sub-liminally presented emotional faces. In a double-blind placebo-controlled between-subject pharmaco-fMRI experiment healthy volunteers received either 24IU of intranasal oxytocin or placebo 45mins before they were presented emotional (happy, angry, fearful, sad, disgusting) faces and mirror-reversed neutral faces masked by neutral faces of the same individual. To ensure attentional processing of the faces subjects were required to perform a simple gender decision task in the scanner and a recognition memory task afterwards. All subjects were additionally assessed for their state and trait anxiety and depression as well as empathy. For the analysis, we will use matlab, SPM and SPSS to conduct structural ROI analysis and two Sample t test.

Registry
clinicaltrials.gov
Start Date
June 2014
End Date
December 2014
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University of Electronic Science and Technology of China
Responsible Party
Principal Investigator
Principal Investigator

Keith Kendrick

Professor / Research group leader

University of Electronic Science and Technology of China

Eligibility Criteria

Inclusion Criteria

  • Healthy subjects, no smoke or drink alcohol, coffee or other stimulants during the day before Experiment.

Exclusion Criteria

  • history of head injury; pregnancy; uterine cavity operations were took within one year; medical or psychiatric illness; rhinitis in case they may not fully absorb the spray.

Arms & Interventions

Placebo

nasal spray

Intervention: Placebo

oxytocin

nasal spray

Intervention: Oxytocin

Outcomes

Primary Outcomes

Number of participants with neuro activity to facial expressions

Time Frame: one week

Similar Trials